Insights

Gathering insights about UBX…

Similar companies to UBX

UBX Tech Stack

UBX uses 8 technology products and services including Cloudflare, XML, Apache HBase, and more. Explore UBX's tech stack below.

Cloudflare
Content Management System
XML
Data Management
Apache HBase
Database
Spring Boot
Frameworks And Libraries
PHP
Programming Languages
Yoast SEO
Search Engines
Appium
Testing And Qa
Robot Framework
Testing And Qa

Media & News

UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the Company will present 36-week data from the ASPIRE Phase 2B study at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting being held on May 4-8, 2025 in Salt Lake City, Utah.
May 01, 2025 | www.globenewswire.com
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2025.
Apr 22, 2025 | www.globenewswire.com
UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study
UNITY Biotechnology stock loses 29% as the mid-stage DME study of the lead candidate, UBX1325, fails to achieve statistical significance for the primary goal.
Mar 25, 2025 | www.zacks.com
Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
Unity Biotechnology, Inc. UBX stock plummeted on Monday after the company released results from its latest study.
Mar 24, 2025 | www.benzinga.com
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient population UBX1325 was non-inferior to aflibercept at week 24 (>90% confidence interval), but did not meet statistical non-inferiority on the average of weeks 20 and 24, the primary analysis endpoint (met at 88% confidence interval) UBX1325-treated patients had a +5.2 letter gain in visual acuity at 24 weeks and a +5.5 letter gain at 36 weeks UBX1325 was numerically superior to aflibercept at 7 out of 10 time points in a pre-specified population with moderately aggressive disease UNITY to host investor call with retinal expert Robert B. Bhisitkul, MD, PhD, today, March 24 at 8:00 a.m.
Mar 24, 2025 | www.globenewswire.com
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025
SOUTH SAN FRANCISCO, Calif., March 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it will host a virtual investor event on Monday, March 24, 2025, at 8:00 AM ET. To register, click here .
Mar 23, 2025 | www.globenewswire.com
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Mar 07, 2025 | www.globenewswire.com

UBX's Email Address Formats

UBX uses at least 1 format(s):

UBX Email Formats	Example	Percentage
First@ubx.ph	John@ubx.ph	56%
FirstLast@ubx.ph	JohnDoe@ubx.ph	26%
FLast@ubx.ph	JDoe@ubx.ph	14%
Middle@ubx.ph	Michael@ubx.ph	4%

Frequently Asked Questions

Where is UBX's headquarters located?

UBX's main headquarters is located at Pasig Cpo, Metro Manila 1600 Philippines. The company has employees across 6 continents, including AsiaNorth AmericaEurope.

What is UBX's stock symbol?

UBX is a publicly traded company; the company's stock symbol is UBX.

What is UBX's official website and social media links?

UBX's official website is ubx.ph and has social profiles on LinkedIn Crunchbase.

What is UBX's NAICS code?

UBX's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does UBX have currently?

As of April 2026, UBX has approximately 265 employees across 6 continents, including AsiaNorth AmericaEurope. Key team members include Chief Executive Officer: D. M.Chief Executive Officer: M. U.Ceo: M. U.. Explore UBX's employee directory with LeadIQ.

What industry does UBX belong to?

UBX operates in the IT Services and IT Consulting industry.

What technology does UBX use?

UBX's tech stack includes CloudflareXMLApache HBaseSpring BootPHPYoast SEOAppiumRobot Framework.

What is UBX's email format?

UBX's email format typically follows the pattern of First@ubx.ph. Find more UBX email formats with LeadIQ.

When was UBX founded?

UBX was founded in 2018.

UBX

Q: What is UBX's official website and social media links?

UBX's official website is ubx.ph. UBX has social profiles on LinkedIn.

Q: How many employees does UBX have currently?

UBX has approximately 265 employees.

Q: What technology does UBX use?

UBX's tech stack includes AWS Data Pipeline, Node.js, OWASP, Google Sheets, BrowserStack.

Q: What is UBX's NAICS code?

UBX's NAICS code is 5415 (Computer Systems Design and Related Services).

IT Services and IT ConsultingMetro Manila, Philippines201-500 Employees

UBX is a premier technology company delivering digital transformation for enterprises and the government, with embedded finance as its core accelerator. We are differentiated by comprehensive local financial expertise and global fintech capabilities through our affiliation with UnionBank of the Philippines and SBI Holdings of Japan.